Multi event Drug Recall Enforcement Report Class II voluntary initiated by Pfizer Inc., originally initiated on 07-10-2025 for the product Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made in Austria, Carton NDC- 60793-702-10 , Syringe NDC-60793-702-04 The product was recalled due to cgmp deviations; particulates identified during visual inspection. The product was distributed nationwide and the recall is currently ongoing.
Recall Enforcement Reports
| Recall Number |
Recall Initiation Date |
Report Date |
Recall Classification |
Quantity |
Product Description |
Recall Reason |
Status |
| D-0545-2025 | 07-10-2025 | 08-06-2025 | Class II | 19,279 vials | Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made in Austria, Carton NDC- 60793-702-10 , Syringe NDC-60793-702-04 | CGMP Deviations; particulates identified during visual inspection | Ongoing |
| D-0544-2025 | 07-10-2025 | 08-06-2025 | Class II | 50,855 2 mL vials | Bicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001. Made in Austria, Carton NDC - 60793-701-10, Syringe NDC - 60793-701-02 | CGMP Deviations; particulates identified during visual inspection | Ongoing |
Recalled Products
